📣 Exciting News! Meet Our New Key Account Manager, Marco 📣 We are happy to welcome Rolf Marco Dietrich to the ARTCLINE team as our new Key Account Manager! With a proven track record of exceptional client relationship management and strategic account development, Marco brings a wealth of experience and expertise to our organization. Marco has spent over 30 years in the healthcare industry, working with a diverse portfolio of clients and driving significant business growth. His dedication to understanding customer needs and delivering tailored solutions aligns perfectly with our commitment to excellence and customer satisfaction. We are confident that Marco will play a fundamental role in develop and strengthening our relationship to our customers and achieving our goals. Please join us in welcoming Marco to the ARTCLINE team! We look forward to our exciting adventure ahead! #NewHire #KeyAccountManager #WelcomeToTheTeam #ClientSuccess #BusinessGrowth #Artcline #Artice #Sepsis
ARTCLINE GmbH
Biotechnologieforschung
Rostock, Mecklenburg-West Pomerania 251 Follower:innen
Innovative therapeutic procedures for Intensive Care Medicine for the treatment of severe infections / sepsis
Info
ARTCLINE GmbH develops innovative therapy methods for intensive care medicine based on immune cells. Our current main project is the development of the so-called ARTICE technology for the treatment of bacterial sepsis. ARTCLINE's vision is the development of innovative immune cell-based therapy approaches and to make the technology available to physicians and hospitals worldwide. The safety and effectiveness of the therapy is our top priority. Our extensive cell biological, clinical and industrial experience in the fields of immunology, sepsis diagnostics and therapy help us to realize our vision. Together with scientists and partners, we focus our research activities on the root causes and correlations of sepsis. For many years, the founders and the team of ARTCLINE GmbH have been successfully involved in the transfer of medical inventions from university research to industrial application. We have an extensive network and long standing experience in the development and successful marketing of medical devices and drugs.
- Website
-
http://www.artcline.de
Externer Link zu ARTCLINE GmbH
- Branche
- Biotechnologieforschung
- Größe
- 11–50 Beschäftigte
- Hauptsitz
- Rostock, Mecklenburg-West Pomerania
- Art
- Kapitalgesellschaft (AG, GmbH, UG etc.)
- Gegründet
- 2007
Orte
-
Primär
Schillingallee 68
Rostock, Mecklenburg-West Pomerania 18057, DE
Beschäftigte von ARTCLINE GmbH
Updates
-
🙌World Blood Donor Day 2024🙌 20 years of celebrating giving: thank you blood donors! Today we would like to thank and recognize the millions of voluntary blood donors who have contributed to the health and well-being of millions of people around the world. Your selfless donations have had a profound impact on the lives and well-being of hundreds of millions of people, as well as their families and communities across the world ❣ Every single blood or plasma donation is a precious lifesaving gift; regular donation is the key to building a safe and sustainable supply. 👉We encourage you, your family and friends: DONATE BLOOD! SAVE LIVES! 💪 #WorldBloodDonorDay #giveblood #savelife World Health Organization
-
ARTCLINE GmbH hat dies direkt geteilt
🏆 BEST ABSTRACT AWARD 2024 🏆 We are delighted to announce that the BEST ABSTRACT AWARD 2024 has been awarded to Dr. med. Gerd Klinkmann from the University of Rostock, Germany. Gerd presented an outstanding abstract at the 41st Vincenza Course on AKI & CRRT titled: "Purified Granulocytes In Extracorporeal Cell Therapy: A Multifaceted Approach To Combat Sepsis-induced Immunoparalysis" This innovative research addresses a critical area in the treatment of sepsis and has the potential to significantly impact patient outcomes. Congratulations to Gerd on this well-deserved recognition! 👏 #ResearchExcellence #MedicalInnovation #SepsisTreatment #ExtracorporealTherapy #UniversityOfRostock #VincenzaCourse2024 #AKI #CRRT #ARTICE
-
ARTCLINE GmbH hat dies direkt geteilt
🏆 BEST ABSTRACT AWARD 2024 🏆 We are delighted to announce that the BEST ABSTRACT AWARD 2024 has been awarded to Dr. med. Gerd Klinkmann from the University of Rostock, Germany. Gerd presented an outstanding abstract at the 41st Vincenza Course on AKI & CRRT titled: "Purified Granulocytes In Extracorporeal Cell Therapy: A Multifaceted Approach To Combat Sepsis-induced Immunoparalysis" This innovative research addresses a critical area in the treatment of sepsis and has the potential to significantly impact patient outcomes. Congratulations to Gerd on this well-deserved recognition! 👏 #ResearchExcellence #MedicalInnovation #SepsisTreatment #ExtracorporealTherapy #UniversityOfRostock #VincenzaCourse2024 #AKI #CRRT #ARTICE
-
🏆 BEST ABSTRACT AWARD 2024 🏆 We are delighted to announce that the BEST ABSTRACT AWARD 2024 has been awarded to Dr. med. Gerd Klinkmann from the University of Rostock, Germany. Gerd presented an outstanding abstract at the 41st Vincenza Course on AKI & CRRT titled: "Purified Granulocytes In Extracorporeal Cell Therapy: A Multifaceted Approach To Combat Sepsis-induced Immunoparalysis" This innovative research addresses a critical area in the treatment of sepsis and has the potential to significantly impact patient outcomes. Congratulations to Gerd on this well-deserved recognition! 👏 #ResearchExcellence #MedicalInnovation #SepsisTreatment #ExtracorporealTherapy #UniversityOfRostock #VincenzaCourse2024 #AKI #CRRT #ARTICE
-
🚀 Exciting News! 🚀 Our CFO, John Peitschner, is joining the health.tech conference in Munich. This conference is a pivotal event for professionals in the health tech sector, bringing together innovators, thought leaders, and startups to shape the future of healthcare. John looks forward to seeing you there and exploring how we can together drive the future of health tech innovation! #HealthTech #Innovation #Startup #Healthcare #MunichConference #Networking #FutureOfHealthcare #JohnPeitschner
-
Wir stellen ein! Key Account Manager (m/w/d) Bewerbungen an [email protected]
-
An important step in donor cell supply 👍 Granulocyte concentrates from pooled buffy coats with extended shelf life according to our purification protocol can be a good alternative to apheresis granulocyte concentrates! 👉 More info here: https://lnkd.in/eZSF8yU2 #artcline #artice #sepsis #immunecelltherapy #apheresis
-
An important step in donor cell supply 👍 Granulocyte concentrates from pooled buffy coats with extended shelf life according to our purification protocol can be a good alternative to apheresis granulocyte concentrates! 👉 More info here: https://lnkd.in/eZSF8yU2 #artcline #artice #sepsis #immunecelltherapy #apheresis
Purified Granulocyte Concentrates from Buffy Coats with Extended Storage Time
karger.com
-
Today we announced the successful completion of two further capital increases. In addition to our founders, in particular family offices from Germany participated in the first capital increase of EUR 0.8 million. Furthermore, a convertible loan from investors was transferred to equity, so that a second capital increase of EUR 3.6 million was implemented. As a result, we received additional equity capital totaling EUR 4.4 million. With the additional funds, we will finance the further execution of our randomized, controlled clinical trial ReActIF-ICE with more than 100 patients with septic shock. The study is currently being conducted in intensive care units in 12 German hospitals and is intended to show not only the safety but also the efficacy of the ARTICE® therapy. #artcline #artice #capitalincrease #sepsis #septicshock See more info here 👇
ARTCLINE successfully completes capital increases of EUR 4.4 million
https://www.artcline.de